Oncology - Breast News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.

Smartest Doc Challenge
MDLinx
Pediatric Oncology Clinical Pearls

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC

Jill Baker
MDLinx Career Center
New Jobs in Your Specialty

MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?

MDLinx Conference Center
MDLinx
June Conference Calendar

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (30) Full Text Articles (905) Focus on Hematology

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

161 Vitamin C intake and breast cancer mortality in a cohort of Swedish women British Journal of Cancer, June 6, 2013 Clinical Article

162 Discordances in estrogen receptor status, progesterone receptor status, and her2 status between primary breast cancer and metastasis Full Text The Oncologist, June 6, 2013 Clinical Article

163 Do reproductive and hormonal risk factors for breast cancer associate with attendance at mammography screening Cancer Causes and Control, June 6, 2013 Clinical Article

164 Raman imaging at biological interfaces: applications in breast cancer diagnosis Full Text Molecular Cancer, June 6, 2013 Clinical Article

165 Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications Full Text BMC Cancer, June 6, 2013 Clinical Article

166 Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent Oncogene, June 6, 2013 Clinical Article

167 Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial Breast Cancer Research and Treatment, June 6, 2013 Clinical Article

168 Sinus involvement in breast cancer: case report The Journal of Laryngology & Otology, June 6, 2013

169 GPER-1 Expression Decreases During Breast Cancer Tumorigenesis Cancer Investigation, June 6, 2013 Clinical Article

170 Targeting treatment resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway Clinical Cancer Research, June 6, 2013 Review Article
Exclusive Author Commentary

171 Effects of a home-based walking training program on cardiorespiratory fitness in breast cancer patients receiving adjuvant chemotherapy: a pilot study European Journal of Physical and Rehabilitation Medicine, June 6, 2013 Clinical Article

172 Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy European Journal of Physical and Rehabilitation Medicine, June 6, 2013 Clinical Article

173 Mammographic and ultrasound features of invasive lobular carcinoma of the breast Journal of Medical Imaging and Radiation Oncology, June 6, 2013 Review Article

174 A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study Annals of Oncology, June 5, 2013

175 Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer Annals of Oncology, June 5, 2013

176 Associations between weight in early adulthood, change in weight and breast cancer risk in postmenopausal women Cancer Epidemiology, Biomarkers & Prevention, June 5, 2013

177 Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening Annals of Internal Medicine, June 5, 2013 Review Article Clinical Article

178 Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line International Journal of Cancer, June 5, 2013 Clinical Article

179 The UK HeartSpare Study: Randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy Radiotherapy & Oncology, June 5, 2013 Clinical Article

180 Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17 Cancer Letters, June 5, 2013 Clinical Article

50 available pages First Previous 9 10 11 12 13 14 15 16 17 18 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Coffee and caffeine intake and breast cancer risk: An updated dose-response meta-analysis of 37 published studies Gynecologic Oncology, May 13, 2013 Evidence Based Medicine

2 Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial analysis Journal of Clinical Oncology, April 30, 2013

3 Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial The Lancet Oncology, May 17, 2013

4 Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer: a randomized biomarker pilot study Clinical Cancer Research, May 6, 2013

5 Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study The Lancet Oncology, May 16, 2013

6 Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: a randomised controlled trial Journal of Cancer Survivorship, May 21, 2013

7 Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab Clinical Cancer Research, May 8, 2013

8 Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer British Journal of Cancer, May 7, 2013

9 Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study Annals of Oncology, April 1, 2013

10 Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study The Lancet Oncology, May 2, 2013

11 Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: Results from the HERA Trial Journal of Clinical Oncology, April 25, 2013

12 Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Annals of Oncology, May 28, 2013

13 Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience Cancer Chemotherapy and Pharmacology, May 15, 2013

14 Use of {beta}-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: A Danish nationwide prospective cohort study Journal of Clinical Oncology, May 9, 2013

15 Which strategies reduce breast cancer mortality most? Cancer, May 1, 2013

16 Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer Clinical Cancer Research, May 24, 2013

17 Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer Journal of Clinical Oncology, May 1, 2013

18 Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer British Journal of Cancer, April 16, 2013

19 Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ Breast Cancer Research and Treatment, May 1, 2013

20 Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial European Journal of Cancer, April 2, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Oncology - Breast News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology